As of January 4th, we have signed an annual CRO accord with Sun Bio Inc. for non clinique efficacy testing and toxicity testing services for drugs under development.
Grâce à cela accord, we will maintain research collaboration from the préclinique phase through to essais cliniques for PEG drugs being developed by Sun Bio, and use this as an opportunity to deepen cooperation in drug and product development sur la base de mutual trust and good faith.
This collaboration a été établi sur la base de trust in RudaCure's efficacy testing and toxicity systems. RudaCure is actuellement conducting efficacy verification, pharmacokinetic studies, and toxicity testing for drugs from Sun Bio, Seoul National University J-MAX, dental product developer ODS, Daewoong Pharmaceutical, and Vivozon.